Nothing Special   »   [go: up one dir, main page]

Pini et al., 1994 - Google Patents

Does chronic use of sumatriptan induce dependence?

Pini et al., 1994

View PDF
Document ID
10248290671549586935
Author
Pini L
Trenti T
Publication year
Publication venue
Headache: The Journal of Head and Face Pain

External Links

Snippet

Reports a case of a 21-yr-old woman suffering from migraines without aura who ingested 100 mg sumatriptan (SU) tablets twice daily and increased to 2–3 tablets daily for approximately 9 mo. The possibility of induced dependence with chronic use of SU was …
Continue reading at headachejournal.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)

Similar Documents

Publication Publication Date Title
HK1047244A1 (en) Synergistic combination of roflumilast and salmeterol
Pini et al. Does chronic use of sumatriptan induce dependence?
EE9700008A (en) A new drug to relieve pain
GR3021438T3 (en) Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes.
IS1907B (en) Use of the chelating agent clioquinol in the preparation of a pharmaceutical composition for the treatment of Alzheimer's disease
HUP0104696A2 (en) Pharmaceutical composition containing 5ht1 receptor agonists and metoclopramide for the treatment of migraine
GB2373726B (en) Pharmaceutical formulations containing zolmitriptan
MY135838A (en) Methods for the treatment of mental disorders
ATE295160T1 (en) COMPOSITIONS CONTAINING ISOVALERIANAMIDE TOGETHER WITH IBUPROFEN
Guthrie et al. Fluoxetine-induced stuttering.
Forster et al. Fluoxetine for premature ejaculation.
Crews et al. Hyponatremia in a patient treated with sertraline.
Lapierre et al. Dyskinesia associated with amoxapine antidepressant therapy: a case report.
Dave Fluoxetine-associated dystonia.
PL348202A1 (en) Pharmaceutically active composition and dispensing device
CA2396209A1 (en) The use of mirtazapine for the treatment of sleep disorders
SE0000698L (en)
RU2002103808A (en) METHOD FOR TREATING PAIN SYNDROME IN ONCOLOGIC PATIENTS
Keinänen et al. Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid
HUP0301408A2 (en) Methods and compositions using sulodexide for the treatment of diabetic nephropathy
SE9904424D0 (en) Use of interleukin-6 in combination with leptin in the treatment of obesity
Moloney Headaches in the perimenopause: Managing techniques
Rose Pilocarpine for patients with Sjogren's syndrome
ES2159479A1 (en) Set of therapeutic indazols consists of inhibitors of cyclooxygenase combating eg. inflammation and Alzheimer's disease
FR2621819A1 (en) Medicament comprising a combination of polymyxin B, gentamicin and amphotericin administered by vaporisation